WO2021118323A1 - 텐덤 인슐린 유사 성장인자-1 및 이를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 - Google Patents
텐덤 인슐린 유사 성장인자-1 및 이를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 Download PDFInfo
- Publication number
- WO2021118323A1 WO2021118323A1 PCT/KR2020/018267 KR2020018267W WO2021118323A1 WO 2021118323 A1 WO2021118323 A1 WO 2021118323A1 KR 2020018267 W KR2020018267 W KR 2020018267W WO 2021118323 A1 WO2021118323 A1 WO 2021118323A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- insulin
- tandem
- growth factor
- present
- Prior art date
Links
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 title claims abstract description 48
- 102100037852 Insulin-like growth factor I Human genes 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000003658 preventing hair loss Effects 0.000 title claims abstract description 20
- 230000001737 promoting effect Effects 0.000 title claims abstract description 18
- 239000004480 active ingredient Substances 0.000 title claims abstract description 17
- 230000003659 hair regrowth Effects 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 claims abstract description 12
- 235000013376 functional food Nutrition 0.000 claims abstract description 8
- 230000036541 health Effects 0.000 claims abstract description 8
- 230000003779 hair growth Effects 0.000 claims description 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 13
- 230000002500 effect on skin Effects 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 210000000642 hair follicle dermal papilla cell Anatomy 0.000 abstract description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 6
- 230000001419 dependent effect Effects 0.000 abstract description 4
- 230000012010 growth Effects 0.000 abstract description 4
- 102000004877 Insulin Human genes 0.000 abstract description 3
- 108090001061 Insulin Proteins 0.000 abstract description 3
- 229940125396 insulin Drugs 0.000 abstract description 3
- 230000002062 proliferating effect Effects 0.000 abstract description 2
- 239000003860 topical agent Substances 0.000 abstract 1
- 210000004209 hair Anatomy 0.000 description 57
- 201000004384 Alopecia Diseases 0.000 description 16
- 239000006071 cream Substances 0.000 description 12
- 230000003676 hair loss Effects 0.000 description 10
- 208000024963 hair loss Diseases 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- 210000003780 hair follicle Anatomy 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- -1 body cleanser Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000003698 anagen phase Effects 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 231100000360 alopecia Toxicity 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000003797 telogen phase Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000000720 eyelash Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 208000003024 Diffuse alopecia Diseases 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000000477 Sirtuin 2 Human genes 0.000 description 2
- 108010041216 Sirtuin 2 Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 238000003235 crystal violet staining Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 201000001297 telogen effluvium Diseases 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010001765 Alopecia syphilitic Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 108010072220 Cyclophilin A Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000021473 Ejaculation disease Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Definitions
- the present invention relates to a tandem insulin-like growth factor-1 and a composition for preventing hair loss or promoting hair growth containing the same as an active ingredient.
- telogen and degenerative phases there are about 100,000 to 150,000 hairs in the human body, and each hair has a different hair cycle and repeats the anagen, catagen, and telogen phases to generate, grow, and fall out. About 15% of the total hair is in the telogen and degenerative phases, so an average of 50 to 100 hairs per day are normally shed and reproduced. This hair growth cycle repeats as a cycle of about 3 to 6 years.
- alopecia means that the period corresponding to the anagen of the hair cycle is shortened due to various reasons, and the ratio of anagen and telogen hairs is relatively increased, so that the number of hair loss is higher than the average value.
- the dermal papilla is the most important part in the development of hair, and there are blood vessels or nerves in the dermal papilla, and it promotes hair growth by supplying nutrients to the hair cells on it.
- the number of these dermal papillaes is determined at birth, and as the number of dermal papillaes disappears, the number of hairs decreases.
- telogen effluvium a general hair loss phenomenon
- telogen effluvium a general hair loss phenomenon
- anagen effluvium an abnormal hair loss phenomenon
- alopecia refers to the latter.
- Types of alopecia include alopecia areata, premature alopecia, androgen alopecia in women, syphilitic alopecia, and male pattern baldness.
- finasteride which is a drug that inhibits the activity of 5- ⁇ reductase that produces dihydrotestosterone, a substance that directly causes hair loss.
- finasteride preparations may cause fetal malformations in pregnant women, and side effects such as decreased libido, erectile dysfunction, and ejaculation disorders have been reported when administered for a long period of time.
- minoxidil-containing hair growth agent which is widely used, is also approved as an over-the-counter drug by the FDA, but it cannot be administered to women and has side effects such as skin irritation, itching, and flushing. Therefore, there is a need to develop a product that is safe for both men and women and has effects of preventing hair loss and hair growth without side effects.
- Korean Patent Application Laid-Open No. 2016-0121122 discloses a nucleotide encoding Sirt2 protein; A composition for preventing hair loss or promoting hair growth is disclosed, comprising a fusion protein of the Sirt2 protein and a protein transduction domain as an active ingredient, and Korean Patent No. 1558222 discloses a composition for preventing hair loss and improving hair growth containing cyclophilin A Although disclosed, the tandem insulin-like growth factor-1 of the present invention and a composition for preventing hair loss or promoting hair growth containing the same as an active ingredient has not been disclosed.
- the present invention has been derived from the above needs, and the present invention provides a tandem insulin-like growth factor-1 and a composition for preventing hair loss or promoting hair growth containing the same as an active ingredient, and the tandem insulin-like growth factor of the present invention- By treatment with 1 (Tandem IGF-1), it was confirmed that the concentration-dependent increase of hair follicle dermal papilla cells, the tandem insulin-like growth factor-1 of the present invention is insulin growth factor-1 (IGF- By confirming that there is a significant hair follicle dermal papilla cell proliferation effect compared to 1), the present invention was completed.
- IGF-1 insulin growth factor-1
- the present invention provides a tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1.
- the present invention provides a cosmetic composition for preventing hair loss or promoting hair growth comprising the tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1 as an active ingredient.
- the present invention provides a skin external preparation for preventing hair loss or promoting hair growth comprising the tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1 as an active ingredient.
- the present invention provides a health functional food composition for preventing hair loss or promoting hair growth comprising the tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1 as an active ingredient.
- the present invention relates to a tandem insulin-like growth factor-1 and a composition for preventing hair loss or promoting hair growth containing the same as an active ingredient, and by treating the tandem insulin-like growth factor-1 (Tandem IGF-1) of the present invention, hair follicle dermal papilla It was confirmed that the cells (Hair follicle dermal papilla cells) increased in a concentration-dependent manner, and the tandem insulin-like growth factor-1 of the present invention was significantly higher than the insulin growth factor-1 (IGF-1) hair follicle dermal papilla cells (Hair follicle dermal papilla). cell) has a proliferation effect.
- IGF-1 insulin growth factor-1
- tandem IGF-1 tandem IGF-1
- A is the Ni resin step result
- B is the final separation and purification result
- tandem IGF-1 tandem insulin-like growth factor-1
- the present invention relates to a tandem insulin-like growth factor-1 protein comprising the amino acid sequence of SEQ ID NO: 1.
- the tandem insulin-like growth factor-1 protein can increase the size of human dermal papilla cells.
- the present invention relates to a cosmetic composition for preventing hair loss or promoting hair growth comprising the tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1 as an active ingredient.
- the cosmetic composition of the present invention includes ingredients commonly used in cosmetic compositions in addition to the active ingredients, for example, fatty substances, organic solvents, solubilizers, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents ( foaming agents), fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents , conventional adjuvants such as lipid vesicles, and carriers.
- ingredients commonly used in cosmetic compositions in addition to the active ingredients for example, fatty substances, organic solvents, solubilizers, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents ( foaming agents), fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, se
- composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, oil, powder foundation, emulsion foundation , wax foundation, spray, and the like. More specifically, the composition of the present invention is a skin, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, eye cream, moisture cream, hand cream, essence, nutrition Essence, pack, cleansing foam, cleansing water, cleansing lotion, cleansing cream, body lotion, body cleanser, soap, powder, hair tonic, hair conditioner, hair essence, hair lotion, hair nourishing lotion, hair shampoo, hair conditioner, hair treatment ment, hair cream, hair nutrition cream, hair moisture cream, hair massage cream, hair wax, hair aerosol, hair pack, hair nutrition pack, hair soap, hair cleansing foam, hair drying agent, hair preservative, hair dye, wave agent for hair, hair It may be prepared in cosmetic formulations of bleach, hair gel, hair glaze, hair dresser, hair lac
- the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide, etc. This can be used.
- lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydro It may contain a propellant such as carbon, propane/butane or dimethyl ether.
- a solvent, solubilizer or emulsifier is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene fatty acid esters of glycol, 1,3-butylglycol oil, glycerol fatty esters, polyethylene glycol or sorbitan.
- the formulation of the cosmetic composition of the present invention is a suspension
- a liquid diluent such as water, ethanol or propylene glycol, ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester , microcrystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracanth
- a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester
- microcrystalline cellulose such as aluminum metahydroxide, bentonite, agar, or tracanth
- the present invention relates to a skin external preparation for preventing hair loss or promoting hair growth comprising the tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1 as an active ingredient.
- the formulation of the external preparation for skin of the present invention can be used by methods such as direct application or dispersion on hair or scalp.
- the hair to which the external preparation for skin of the present invention is applied includes hair roots and hair follicles of the head, hair and eyelashes, eyebrows, beard, armpits, pubic hair, and all parts of the body having hair roots and hair follicles. Therefore, the present invention is a hair tonic, hair lotion, hair cream, hair spray, hair mousse, hair gel, hair conditioner, hair shampoo, hair conditioner, hair pack, hair treatment, eyebrow hair growth agent, eyelash hair growth agent or eyelash nutrient agent, or for pets It can be used as a shampoo and conditioner for pets.
- the dose of the external preparation for skin according to the present invention may be appropriately determined in consideration of gender, age, hair loss symptoms, hair condition, and the like.
- the external preparation for skin having a function of promoting hair growth and preventing hair loss according to the present invention may be added as a raw material for cosmetics and pharmaceuticals.
- the present invention relates to a health functional food composition for preventing hair loss or promoting hair growth comprising the tandem insulin-like growth factor-1 protein consisting of the amino acid sequence of SEQ ID NO: 1 as an active ingredient.
- composition is preferably prepared in any one formulation selected from powder, granule, pill, tablet, capsule, candy, syrup and beverage, but is not limited thereto.
- the health functional food composition of the present invention may be prepared by adding the tandem insulin-like growth factor-1 protein as it is or by mixing it with other foods or food ingredients, and may be appropriately prepared according to a conventional method.
- foods to which the tandem insulin-like growth factor-1 protein can be added include dairy products including caramel, meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, and ice cream; It may be in any one form selected from various soups, beverages, teas, drinks, alcoholic beverages and vitamin complexes, and includes all health functional foods in a conventional sense. That is, there is no particular limitation on the type of the food.
- the health functional food composition includes various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavorants, colorants and enhancers (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners , a pH adjuster, a stabilizer, a preservative, glycerin, alcohol, a carbonation agent used in carbonated beverages, and the like. It may also contain pulp for the production of natural fruit juices and vegetable beverages.
- the above components may be used independently or in combination.
- the health functional food composition of the present invention may contain various flavoring agents or natural carbohydrates as additional ingredients, and the natural carbohydrates include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, dextrin, and cyclo polysaccharides such as dextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol.
- the proportion of the natural carbohydrate is not very important, but with respect to 100 g of the composition of the present invention, it is preferably 0.01 to 0.04 g, more preferably 0.02 to 0.03 g, but is not limited thereto.
- natural sweeteners such as tau martin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used.
- tandem IGF-1 tandem insulin-like growth factor-1
- IGF-1 insulin-like growth factor-1
- the tandem insulin-like growth factor-1 of the present invention has two consecutive sequences of insulin-like growth factor-1, and consists of the following amino acid sequence.
- Tandem insulin-like growth factor-1 protein sequence
- the tandem insulin-like growth factor-1 protein and the insulin-like growth factor-1 protein-treated group increased hair follicle tissue cells in a concentration-dependent manner compared to the untreated group.
- tandem insulin-like growth factor-1 Since the molecular weight of tandem insulin-like growth factor-1 is twice that of insulin-like growth factor-1, when the tandem insulin-like growth factor-1 and insulin-like growth factor-1 of the present invention are treated at the same ppm concentration, IGF-1 The number of moles of Tendem IGF-1 compared to the number of moles is halved. Therefore, it can be seen that there is a similar or increased proliferative effect of dermal papilla cells in the hair follicles even when tendem IGF-1 is treated with half the number of moles. Therefore, the tandem insulin-like growth factor-1 of the present invention has a significant dermal papilla hair follicle compared to insulin-like growth factor-1. It can be seen that there is a cell proliferation effect.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (5)
- 서열번호 1의 아미노산 서열로 이루어진 텐덤 인슐린 유사 성장인자-1 단백질.
- 제1항에 있어서, 상기 텐덤 인슐린 유사 성장인자-1 단백질은 인간 모유두세포의 크기를 증가시키는 것을 특징으로 하는 텐덤 인슐린 유사 성장인자-1 단백질.
- 서열번호 1의 아미노산 서열로 이루어진 텐덤 인슐린 유사 성장인자-1 단백질을 유효성분으로 포함하는 탈모방지 또는 발모촉진용 화장료 조성물.
- 서열번호 1의 아미노산 서열로 이루어진 텐덤 인슐린 유사 성장인자-1 단백질을 유효성분으로 포함하는 탈모방지 또는 발모촉진용 피부 외용제.
- 서열번호 1의 아미노산 서열로 이루어진 텐덤 인슐린 유사 성장인자-1 단백질을 유효성분으로 포함하는 탈모방지 또는 발모촉진용 건강기능식품 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2019-0166242 | 2019-12-13 | ||
KR20190166242 | 2019-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021118323A1 true WO2021118323A1 (ko) | 2021-06-17 |
Family
ID=76330232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/018267 WO2021118323A1 (ko) | 2019-12-13 | 2020-12-14 | 텐덤 인슐린 유사 성장인자-1 및 이를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20210075897A (ko) |
WO (1) | WO2021118323A1 (ko) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040076780A (ko) * | 2003-02-26 | 2004-09-03 | (주)케어젠 | 재조합 인슐린 유사 성장인자를 함유하는 화장료 조성물 |
KR20070091568A (ko) * | 2006-03-06 | 2007-09-11 | (주)케어젠 | 인슐린 유사 성장인자―1의 활성을 가지는 펩타이드 및그의 용도 |
US20090038022A1 (en) * | 2004-11-29 | 2009-02-05 | Nadia Rosenthal | IGF-1 Novel peptides |
KR20100035240A (ko) * | 2008-09-26 | 2010-04-05 | (주)케어젠 | 성장인자―관련 펩타이드 및 그의 용도 |
KR20190073147A (ko) * | 2017-12-18 | 2019-06-26 | 주식회사 엘지생활건강 | 인슐린유사 성장인자-1의 융합 단백질을 포함하는 피부개선용 화장료 조성물 |
-
2020
- 2020-12-14 WO PCT/KR2020/018267 patent/WO2021118323A1/ko active Application Filing
- 2020-12-14 KR KR1020200174578A patent/KR20210075897A/ko not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040076780A (ko) * | 2003-02-26 | 2004-09-03 | (주)케어젠 | 재조합 인슐린 유사 성장인자를 함유하는 화장료 조성물 |
US20090038022A1 (en) * | 2004-11-29 | 2009-02-05 | Nadia Rosenthal | IGF-1 Novel peptides |
KR20070091568A (ko) * | 2006-03-06 | 2007-09-11 | (주)케어젠 | 인슐린 유사 성장인자―1의 활성을 가지는 펩타이드 및그의 용도 |
KR20100035240A (ko) * | 2008-09-26 | 2010-04-05 | (주)케어젠 | 성장인자―관련 펩타이드 및 그의 용도 |
KR20190073147A (ko) * | 2017-12-18 | 2019-06-26 | 주식회사 엘지생활건강 | 인슐린유사 성장인자-1의 융합 단백질을 포함하는 피부개선용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20210075897A (ko) | 2021-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20060128964A (ko) | 마카 추출물의 제조 방법 | |
CN107530258B (zh) | 用于促进毛发生长或毛发修复和用于抗炎的组合物 | |
KR20140115400A (ko) | 붉나무 추출물을 유효성분으로 포함하는 탈모방지 및 발모촉진용 두피케어조성물 | |
EP3812393A1 (en) | Composition for preventing hair loss or promoting hair growth | |
KR20190125775A (ko) | 식물 유래 오일을 유효성분으로 함유하는 모발 성장촉진 또는 탈모방지용 조성물 | |
RU2711298C2 (ru) | Композиция для предотвращения или лечения выпадения волос, содержащая белок хемокинового лиганда 1, содержащего с-х-с мотив (cxcli) | |
KR102075842B1 (ko) | 한약재 em 발효액을 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 | |
WO2021118323A1 (ko) | 텐덤 인슐린 유사 성장인자-1 및 이를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 | |
WO2018190695A1 (ko) | 나한과 잔사 추출물을 유효성분으로 함유하는 피부주름의 예방 또는 개선용 조성물 | |
KR102386120B1 (ko) | 밀크씨슬 꽃 추출물을 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 조성물 | |
KR20210131598A (ko) | 동백나무 과피 추출물을 유효성분으로 포함하는 탈모 방지 또는 발모 촉진용 조성물 | |
KR102231474B1 (ko) | 위타페린 a를 유효성분으로 포함하는 여드름의 예방, 개선 또는 치료용 조성물 | |
KR20220096277A (ko) | 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 조성물 | |
RU2709195C1 (ru) | Фармацевтическая композиция для предотвращения или лечения выпадения волос, содержащая белок-хемокинового лиганда 1, содержащего с-х-с мотив (схсl1), и миноксидил в качестве активных ингредиентов | |
JP2004149729A (ja) | 抗酸化剤 | |
CN107530253B (zh) | 含有补骨脂定的用于促进生发及/或育发的组合物 | |
KR102435396B1 (ko) | 이소프로스타노이드를 포함하는 탈모 방지 및 발모 촉진용 조성물 | |
RU2794988C1 (ru) | Композиция для предупреждения выпадения волос или стимуляции роста волос | |
KR102360927B1 (ko) | 런시나트사이드를 포함하는 탈모 방지 및 발모 촉진용 조성물 | |
KR20190124853A (ko) | 유자씨 오일 및 콜라겐 활성 펩티드를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 | |
KR102343372B1 (ko) | 탈모 예방 또는 치료용 약학 조성물 | |
KR102600558B1 (ko) | 아트라릭산을 포함하는 발모 촉진 및 탈모 방지용 조성물 | |
KR102276483B1 (ko) | 식물 복합 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 조성물 | |
KR101933835B1 (ko) | 플럼바긴 및 생강 추출물을 포함하는 피부 미백용 조성물 | |
KR102268761B1 (ko) | 론코카르푸스 에리오칼릭스 추출물을 이용한 발모 촉진 또는 탈모 억제용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20898900 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20898900 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 08.12.2022) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20898900 Country of ref document: EP Kind code of ref document: A1 |